Tumor marker and its use

Details Tumor marker and its use Tumor marker and its use

2003-02-27

2008-12-09

Canella, Karen A (Department: 1642)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023500, C435S069100

Reexamination Certificate

active

07462704

ABSTRACT:
The invention provides a new kind of tumor marker RL9/RL10 protein, the polynucleotide encoding the polypeptide, and the method of producing RL9/RL10 protein by recombinant technology. The invention also discloses the use of RL9/RL10 protein and the polynucleotides encoding RL9/RL10 protein, e.g., in diagnosing and treating tumor, as well as the pharmaceutical composition containing RL9/RL10 protein or the antibody against it.

REFERENCES:
patent: 2003/0105000 (2003-06-01), Pero et al.
patent: 2005/0074754 (2005-04-01), Okubo et al.
patent: WO0183545 (2001-11-01), None
Greenbaum et al. (Genome Biology, 2003, vol. 4, Issue 9, pp. 117.1-117.8).
Brennan et al (J. Autoimmunity, 1989, 2 (suppl.): 177-186).
Zimmer (Cell Motility and the Cytoskeleton, 1991. 20:325-337).
Hell et al. (Laboratory Investigation, 1995, 73: 492-496).
Fu et al. (EMBO J., 1996, 15:43982-4401).
Vallejo et al. (Biochimie, 2000 82:1129-1133).
Taber's Cyclopedic Medical Dictionary (1985, F.A. Davis Company, Philadelphia, p. 274).
Busken, C et al, (Digestive Disease Week Abstracts and Itinerary Planner, 2003, abstract No:850).
Kaiser (Science, 2006, 313, 1370).
Bowie et al (Science, 1990, 257:1306-1310).
Burgess et al (J of Cell Bio. 111:2129-2138, 1990).
Lazar et al. (Molecular and Cellular Biology 8:1247-1252 (1988)).
Scott et al (Nature Genetics, 1999, 21:440-443).
GenBank: NP631904, GI: 21040248, Dec. 23, 2002, Conejo-Garcia, J.-R., et al.
Bauer, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 1999; 285(5428): 727-9.
Cerwenka, et al., Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci USA. 2001; 98(20): 11521-6.
Cerwenka, et al., Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 2000; 12(6): 721-7.
Diefenbach, et al. Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 2001; 413(6852): 165-71.
Wu, et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 1999; 285(5428): 730-2.
Yi Min, et al. Diagnostic value of the three tumour marker on gastric cancer. Journal of Wenzhou Medical College. 2001; 31(2). (In Chinese with English translation and certificate).
Zhang Zhenyu, et al. Diagnostic value of serum CEA, CA50, CA 19-9 and CA 125 on gastric cancer. Mod Diagn Treat. 2001; 12(3): 162. (In Chinese with English translation and certificate).

Affiliated with

Also associated with

Rating

Tumor marker and its use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumor marker and its use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor marker and its use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4026548